Akorn (AKRX) Shares Gap Up to $3.03

Akorn, Inc. (NASDAQ:AKRX) gapped up before the market opened on Monday . The stock had previously closed at $2.93, but opened at $3.03. Akorn shares last traded at $3.04, with a volume of 3083939 shares traded.

A number of brokerages recently weighed in on AKRX. BidaskClub upgraded Akorn from a “hold” rating to a “buy” rating in a research note on Monday, January 7th. Piper Jaffray Companies set a $8.00 target price on Akorn and gave the company a “buy” rating in a research report on Friday, March 1st. SunTrust Banks assumed coverage on Akorn in a research report on Tuesday, March 19th. They set a “hold” rating and a $4.00 target price on the stock. Royal Bank of Canada set a $4.00 target price on Akorn and gave the company a “hold” rating in a research report on Friday, March 1st. Finally, Zacks Investment Research raised Akorn from a “sell” rating to a “hold” rating in a research report on Monday, December 31st. Six analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Akorn has an average rating of “Hold” and a consensus target price of $8.17.

The company has a quick ratio of 2.40, a current ratio of 3.42 and a debt-to-equity ratio of 1.85. The firm has a market cap of $377.37 million, a price-to-earnings ratio of -8.32 and a beta of 2.75.

Akorn (NASDAQ:AKRX) last announced its quarterly earnings data on Thursday, February 28th. The company reported ($0.32) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.31). The firm had revenue of $153.39 million during the quarter, compared to analyst estimates of $164.75 million. Akorn had a negative net margin of 57.91% and a negative return on equity of 13.34%. The firm’s revenue for the quarter was down 17.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.14 earnings per share. Research analysts anticipate that Akorn, Inc. will post -0.28 EPS for the current fiscal year.

Hedge funds have recently made changes to their positions in the company. BlackRock Inc. grew its holdings in Akorn by 43.7% during the fourth quarter. BlackRock Inc. now owns 15,707,461 shares of the company’s stock worth $53,248,000 after acquiring an additional 4,776,900 shares during the period. Norges Bank acquired a new stake in Akorn during the fourth quarter worth about $4,789,000. Millennium Management LLC grew its holdings in Akorn by 166.8% during the fourth quarter. Millennium Management LLC now owns 2,068,124 shares of the company’s stock worth $7,011,000 after acquiring an additional 1,292,897 shares during the period. Dimensional Fund Advisors LP grew its holdings in Akorn by 77.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,648,375 shares of the company’s stock worth $8,978,000 after acquiring an additional 1,153,675 shares during the period. Finally, Assenagon Asset Management S.A. acquired a new stake in Akorn during the fourth quarter worth about $3,522,000. 69.48% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: This report was first published by Modern Readers and is the property of of Modern Readers. If you are accessing this report on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at https://www.modernreaders.com/news/2019/04/17/akorn-akrx-shares-gap-up-to-3-03.html.

About Akorn (NASDAQ:AKRX)

Akorn, Inc, a specialty generic pharmaceutical company, develops, manufactures, and markets generic and branded prescription pharmaceuticals, over-the-counter (OTC) consumer health products, and animal health pharmaceuticals in the United States and internationally. The company operates in two segments, Prescription Pharmaceuticals and Consumer Health.

See Also: What are popular green investing opportunities?

Receive News & Ratings for Akorn Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akorn and related companies with MarketBeat.com's FREE daily email newsletter.